AA
IMGN

ALPS Advisors’s Immunogen Inc IMGN Stock Holding History

ALPS Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-148,874
Closed -$572K – 1041
2023
Q1 		$572K Sell
148,874
-766
-0.5% -$3.27K 0.01% 568
2022
Q4 		$742K Buy
149,640
+29,172
+24% +$158K 0.01% 530
2022
Q3 		$576K Sell
120,468
-10,352
-8% -$54.6K 0.01% 569
2022
Q2 		$589K Sell
130,820
-95,829
-42% -$416K 0.01% 553
2022
Q1 		$1.08M Sell
226,649
-21,110
-9% -$117K 0.01% 305
2021
Q4 		$1.84M Sell
247,759
-6,983
-3% -$43.4K 0.02% 298
2021
Q3 		$1.44M Sell
254,742
-8,615
-3% -$49.8K 0.01% 353
2021
Q2 		$1.74M Buy
+263,357
New +$1.84M 0.02% 344
2020
Q4 		– Sell
-222,588
Closed -$801K – 888
2020
Q3 		$801K Sell
222,588
-15,322
-6% -$61.9K 0.01% 373
2020
Q2 		$1.09M Sell
237,910
-75,503
-24% -$321K 0.01% 305
2020
Q1 		$1.07M Buy
313,413
+9,525
+3% +$41.6K 0.02% 268
2019
Q4 		$1.55M Buy
303,888
+5,007
+2% +$17K 0.01% 261
2019
Q3 		$723K Sell
298,881
-14,111
-5% -$37.5K 0.01% 378
2019
Q2 		$679K Sell
312,992
-47,119
-13% -$111K 0.01% 467
2019
Q1 		$976K Buy
360,111
+15,550
+5% +$67.4K 0.01% 332
2018
Q4 		$1.65M Buy
344,561
+80,850
+31% +$491K 0.01% 239
2018
Q3 		$2.5M Buy
263,711
+70,640
+37% +$679K 0.02% 220
2018
Q2 		$1.88M Buy
193,071
+15,693
+9% +$165K 0.01% 235
2018
Q1 		$1.87M Buy
177,378
+30,829
+21% +$305K 0.01% 219
2017
Q4 		$939K Buy
+146,549
New +$904K 0.01% 274
2016
Q2 		– Sell
-97,910
Closed -$834K – 639
2016
Q1 		$834K Sell
97,910
-16,680
-15% -$141K 0.01% 194
2015
Q4 		$1.55M Sell
114,590
-20,310
-15% -$250K 0.02% 190
2015
Q3 		$12.9K Buy
134,900
+49,364
+58% +$722K 0.01% 199
2015
Q2 		$1.23M Buy
85,536
+42,752
+100% +$470K 0.01% 201
2015
Q1 		$383K Buy
+42,784
New +$310K ﹤0.01% 616

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ALPS Advisors's IMGN Position: Q2 2023 in Review

ALPS Advisors sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 148,874 shares — an estimated $572K sold.

ALPS Advisors first reported a position in IMGN in Q1 2015 and held it in 25 quarters. The position peaked at $2.5M in Q3 2018. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • ALPS Advisors reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • ALPS Advisors sold 148,874 Immunogen Inc shares in Q2 2023, an estimated $572K.
  • ALPS Advisors first reported a position in Immunogen Inc in Q1 2015 and held it in 25 quarters.
  • ALPS Advisors's Immunogen Inc position peaked at $2.5M in Q3 2018.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.